July 2024 – Page 204 – Get News Story

Zil US Offers API Services to Enhance Business Capabilities

Businesses can create a custom payment platform tailored to their needs.

Zil US provides an API for businesses that can be personalized based on business requirements. Using the Zil US API, users can enhance their brand presence in financial transactions. The platform empowers companies to leverage a trusted partner’s expertise, infrastructure, and resources, enabling them to develop and deliver innovative products and services effortlessly. This eliminates the need for building solutions from scratch, giving businesses a significant competitive advantage.

Zil US’s API service enables businesses to customize products and services to align perfectly with their brand, enhancing brand consistency and fostering customer loyalty. With various payment options, including ACH, wire transfers, international payments, and virtual card payments, clients can enjoy a personalized payment experience.

Zil US also simplifies business payments by allowing multiple accounts to manage expenses. Businesses can assign each account specific purposes tailored to streamline financial tracking and management. By accessing Zil US API helps businesses reinforces brand identity and strengthens customer trust but also drives revenue growth, supports expansion efforts, and offers dedicated customer support and advanced financial tools tailored to the brand’s specific needs.

Zil Money Corporation, the parent company of OnlineCheckWriter.com – powered by Zil Money, Zil US, and ZilMoney.com, is committed to streamlining business finance. Zil US’s global expansion is based on continuous innovation and service enhancements, providing a comprehensive and user-friendly platform to meet diverse financial needs worldwide. The platform offers convenient mobile access through its dedicated app, available for download from both the Google Play Store and the iOS App Store.

To view original press release, please visit : https://www.prbuzz.co/pr/248490/zil-us-offers-api-services-to-enhance-business-capabilities

Media Contact
Company Name: Zil Money Corporation
Contact Person: Tahir Haneef
Email: Send Email
Phone: 1 408-222-8012
Country: United States
Website: https://zilmoney.com

Small Cell Lung Cancer Pipeline 2024 | Staidson (Beijing) Biopharmaceuticals Co., Ltd, Cartesian Therapeutics, GEn1E Lifesciences, Aqualung Therapeutics Corp., Theratome Bio,

DelveInsight’s, “Small Cell Lung Cancer Pipeline Insight 2024” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Small Cell Lung Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Discover the latest drugs and treatment options in the Small Cell Lung Cancer Pipeline. Dive into DelveInsight’s comprehensive report today! @ Small Cell Lung Cancer Pipeline Outlook

Key Takeaways from the Small Cell Lung Cancer Pipeline Report

July 2024:- Merck Sharp & Dohme LLC- A Phase 3, Multicenter, Randomized, Double-Blind Study of MK-7684 With Pembrolizumab as a Coformulation (MK-7684A) Versus Pembrolizumab Monotherapy as First Line Treatment for Participants With PD-L1 Positive Metastatic Non-Small Cell Lung Cancer. The goal of this study is to learn if people who receive vibostolimab and pembrolizumab live longer overall and without the cancer getting worse than people who receive pembrolizumab alone.
July 2024:- AbbVie- A Randomized, Phase 2/3 Study to Evaluate the Optimal Dose, Safety, and Efficacy of Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC). There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic and may require frequent medical assessments, blood tests, questionnaires, and scans.
DelveInsight’s Small Cell Lung Cancer pipeline report depicts a robust space with 100+ active players working to develop 100+ pipeline therapies for Small Cell Lung Cancer treatment.
The leading Small Cell Lung Cancer Companies include Staidson (Beijing) Biopharmaceuticals Co., Ltd, Cartesian Therapeutics, GEn1E Lifesciences, Aqualung Therapeutics Corp., Theratome Bio, Meridigen Biotech Co., Ltd., Dompé Farmaceutici S.p.A., Veru Healthcare, Windtree Therapeutics, MiNK Therapeutics, Avalo Therapeutics, Inc., Cynata Therapeutics Limited, Thiogenesis Therapeutics, Inc., Arch Biopartners, Ibudilast, and others.
Promising Small Cell Lung Cancer Therapies in the various stages of development include Amivantamab, Lazertinib, Pemetrexed 500 mg, AL8326 tablets, durvalumab, and others.

Stay ahead with the most recent pipeline outlook for Small Cell Lung Cancer. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ Small Cell Lung Cancer Approved Drugs

Small Cell Lung Cancer Emerging Drugs Profile

AMG 757: Amgen

AMG 757 is a half-life extended (HLE) anti- delta-like ligand 3 (DLL3) x anti-CD3 BiTE (bispecific T cell engager) molecule. It is being investigated in Phase I clinical studies for the treatment of prostate cancer and Small cell lung cancer.

APG-1252: Ascentage Pharma

APG-1252 is a highly potent, small-molecule based Bcl-2 family protein inhibitor drug. APG-1252 is designed to treat SCLC, NSCLC, lymphoma, and other solid tumors by selectively blocking Bcl-2 and Bcl-xL to restore the apoptosis process. The drug is in Phase I/II clinical studies for the treatment of SCLC.

Explore groundbreaking therapies and clinical trials in the Small Cell Lung Cancer Pipeline. Access DelveInsight’s detailed report now! @ Small Cell Lung Cancer Treatment Drugs

Small Cell Lung Cancer Companies

Staidson (Beijing) Biopharmaceuticals Co., Ltd, Cartesian Therapeutics, GEn1E Lifesciences, Aqualung Therapeutics Corp., Theratome Bio, Meridigen Biotech Co., Ltd., Dompé Farmaceutici S.p.A., Veru Healthcare, Windtree Therapeutics, MiNK Therapeutics, Avalo Therapeutics, Inc., Cynata Therapeutics Limited, Thiogenesis Therapeutics, Inc., Arch Biopartners, Ibudilast, and others.

Small Cell Lung Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration

Oral
Parenteral
Intravitreal
Subretinal
Topical
Molecule Type

Small Cell Lung Cancer Products have been categorized under various Molecule types such as

Monoclonal Antibody
Peptides
Polymer
Small molecule
Gene therapy
Product Type

Unveil the future of Small Cell Lung Cancer Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight’s expert analysis @ Small Cell Lung Cancer Market Drivers and Barriers

Scope of the Small Cell Lung Cancer Pipeline Report

Coverage- Global
Small Cell Lung Cancer Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
Small Cell Lung Cancer Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
Small Cell Lung Cancer Companies- Staidson (Beijing) Biopharmaceuticals Co., Ltd, Cartesian Therapeutics, GEn1E Lifesciences, Aqualung Therapeutics Corp., Theratome Bio, Meridigen Biotech Co., Ltd., Dompé Farmaceutici S.p.A., Veru Healthcare, Windtree Therapeutics, MiNK Therapeutics, Avalo Therapeutics, Inc., Cynata Therapeutics Limited, Thiogenesis Therapeutics, Inc., Arch Biopartners, Ibudilast, and others.
Small Cell Lung Cancer Therapies- Amivantamab, Lazertinib, Pemetrexed 500 mg, AL8326 tablets, durvalumab, and others.

Get the latest on Small Cell Lung Cancer Therapies and clinical trials. Download DelveInsight’s in-depth pipeline report today! @ Small Cell Lung Cancer Companies, Key Products and Unmet Needs

Table of Content

Introduction
Executive Summary
Small Cell Lung Cancer: Overview
Pipeline Therapeutics
Therapeutic Assessment
Small Cell Lung Cancer – DelveInsight’s Analytical Perspective
In-depth Commercial Assessment
Small Cell Lung Cancer Collaboration Deals
Late Stage Products (Phase III)
Pembrolizumab: Merck & Co
Drug profiles in the detailed report…..
Mid Stage Products (Phase II)
Dostarlimab: GlaxoSmithKline
Drug profiles in the detailed report…..
Early Stage Products (Phase I)
AMG 757: Amgen
Drug profiles in the detailed report…..
Preclinical/Discovery Stage Products
S 055746: Vernalis
Drug profiles in the detailed report…..
Inactive Products
Small Cell Lung Cancer Key Companies
Small Cell Lung Cancer Key Products
Small Cell Lung Cancer- Unmet Needs
Small Cell Lung Cancer- Market Drivers and Barriers
Small Cell Lung Cancer- Future Perspectives and Conclusion
Small Cell Lung Cancer Analyst Views
Small Cell Lung Cancer Key Companies
Appendix

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432,
City: Las Vegas
State: United States
Country: India
Website: https://www.delveinsight.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Small Cell Lung Cancer Pipeline 2024 | Staidson (Beijing) Biopharmaceuticals Co., Ltd, Cartesian Therapeutics, GEn1E Lifesciences, Aqualung Therapeutics Corp., Theratome Bio,

Cell Culture Market worth $57.9 billion by 2029

“Asia Pacific is anticipated to register fastest growth in the cell culture owing to the increasing focus on advancement of biopharmaceutical industry, high government investments & fundings for R&D, and growing demand for cell and gene therapy.”

Browse 997 market data Tables and 54 Figures spread through 772 Pages and in-depth TOC on “Cell Culture Market by Product (Consumables (Media, Sera, Reagents), Vessels (Roller Bottle, Cell Factory, Flask), Equipment (SU Bioreactor, Storage, Incubators, Filtration)), Application (mAbs, Vaccines, Regenerative Medicine) – Global Forecast to 2029

Cell Culture Market in terms of revenue was estimated to be worth $30.9 billion in 2024 and is poised to reach $57.9 billion by 2029, growing at a CAGR of 13.4% from 2024 to 2029 according to a new report by MarketsandMarkets™. Some of the factors contributing to the growth of the global cell culture market includes increasing fundings and support from government and private organizations for cell-based research, growing popularity for biosimilars and monoclonal antibodies, and growth in advanced therapy medicinal products. However, high cost of cell biology research and limitations in producing high density cell culture are expected to hinder market growth.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=559

The consumables segment accounted for the largest share of the product segment in the cell culture market in 2023.

Based on products, the cell culture market is segmented into consumables and equipment. Consumables are further segmented into sera, media, reagents; vessels; and accessories. Equipment is further categorized as bioreactors, storage equipment, and other equipment. Consumables segment dominated the market in 2023 and is expected to grow at a higher rate during the forecast. The largest share of the segment is attributed to repetitive purchase of media & reagents, and growing R&D activities to develop and manufacture advanced therapies.

The pharmaceutical and biotechnology companies’ segment is estimated to register the highest growth rate during the forecast period in the cell culture market.

Based on end user, the cell culture market is segmented into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, research & academic institutes, and other end users. The pharmaceutical & biotechnology companies’ segment is estimated to register the highest growth rate during the forecast period. The rising demand for advanced therapies such as regenerative medicine due to increasing prevalence of chronic diseases is expected to boost the growth of pharmaceutical & biotechnology companies’ segment in coming years.

The Asia Pacific region is the fastest-growing region of the cell culture market in 2023.

Based on the region, the cell culture market is segmented into major regions: North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The Asia Pacific is anticipated to register fastest growth in the cell culture owing to the increasing focus on advancement of biopharmaceutical industry, high government investments & fundings for R&D, and growing demand for cell and gene therapy.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=559

Cell Culture Market Dynamics:

Drivers:

Increasing fundings for cell-based research

Restraints:

High cost of cell biology research

Opportunities:

Growth opportunities in emerging economies

Challenge:

Disposal of plastic consumables

Key Market Players of Cell Culture Industry:

Key players in the cell culture market include Thermo Fisher Scientific Inc. (US), Danaher Corporation (US), Sartorius AG (Germany), Merck KGaA (Germany), Corning Incorporated (US), FUJIFILM Holdings Corporation (Japan), BD (US) Eppendorf SE (Germany), Lonza (Switzerland), Getinge AB (Sweden), Agilent Technologies, Inc. (US), HiMedia Laboratories (India), Miltenyi Biotec (Germany), STEMCELL Technologies (Canada), Solida Biotech GmbH (Germany), Caisson Labs (US), PromoCell GmbH (Germany), InvivoGen (France), PAN-Biotech (Germany), Cellexus (Scotland), Meissner Filtration Products Inc. (US), Adolf Kühner AG (Switzerland), Bio-Techne (US), Advancion Corporation (US), and BioSpherix, Ltd. (US).

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side- 70% and Demand Side 30%
By Designation: Managers – 45%, CXO & Directors – 30%, and Executives – 25%
By Region: North America – 40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%

Recent Developments of Cell Culture Industry:

In September 2023, Thermo Fisher Scientific launched the Gibco CTS Detachable Dynabeads, a groundbreaking platform with an innovative active-release mechanism designed for the clinical and commercial operation of cell therapy manufacturing.
In December 2023, Danaher acquired Abcam, a provider of validated antibodies, reagents, biomarkers, and assays crucial for drug discovery, life sciences research, and diagnostics. Within Danaher’s Life Sciences segment, Abcam will continue to operate independently, aligning with Danaher’s mission to advance disease understanding and expedite drug discovery.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=559

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/cell-culture-market-media-sera-reagents-559.html

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Cell Culture Market worth $57.9 billion by 2029

Literary Titan Awards Kay A. Oliver with Coveted Gold and Silver Book Accolades for Fiction in July 2024

“Disturbed Tombs” and “Road to Elysium” Triumph with Unforgettable Stories of Love, Tragedy, Discovery, Peace, and Redemption.

We are thrilled to announce that acclaimed author Kay A. Oliver has won both the Gold Book and Silver Book Awards from Literary Titan for her exceptional fiction. Oliver’s debut, “Disturbed Tombs,” received the Gold Book Award, celebrating its unparalleled storytelling and originality.

“Road to Elysium,” another captivating work by Oliver, earned the Silver Book Award for its profound exploration of love, tragedy, and redemption. Both novels have garnered numerous accolades, solidifying Oliver’s status as a celebrated author.

Oliver’s literary masterpieces, “Disturbed Tombs” and “Road to Elysium,” have not only captured hearts but also earned critical acclaim. Reviewer A. Prasad describes Oliver’s writing as a masterful blend of love, friendship, and complex human experiences, creating deeply moving and engaging narratives.

“Disturbed Tombs” transports readers into a world filled with mystery and suspense, where secrets of the past unravel in the most unexpected ways. Its intricate plot and richly developed characters have made it a standout in contemporary fiction, earning it the prestigious Gold Book Award.

“Road to Elysium,” on the other hand, delves into the profound themes of love, tragedy, and redemption. Through its compelling narrative and emotional depth, the novel explores the resilience of the human spirit. This powerful story has resonated with readers and critics alike, earning it the Silver Book Award.

Oliver’s latest release, “Love’s Calculated Risk,” promises to enchant readers with action, adventure, and romance. Featuring gripping storytelling and unexpected twists, this novel is a testament to Oliver’s versatility and skill as a writer. Fans and new readers alike can expect a thrilling journey filled with unforgettable characters and heart-pounding moments.

For more information about Kay A. Oliver’s award-winning novels and latest releases, visit her official website – https://kayaoliver.com

ABOUT THE AUTHOR:

Kay A. Oliver is a celebrated author and esteemed Hollywood insider known for her innate storytelling abilities. With a degree in Communication from California State University, Fullerton, and decades of experience in Hollywood, Oliver crafts captivating, easy-to-read stories brimming with unexpected twists. Her writing blends her Hollywood experience with unbridled imagination, making her a legendary storyteller of our era.

Oliver also holds a master’s degree in business and finance and remains an active TV Academy member. Recently inducted into Marquis Who’s Who, she continues to be recognized for her outstanding contributions to writing and storytelling.

Oliver’s unique background and extensive experience in both the literary and entertainment industries contribute to her distinctive voice as a writer. Her novels reflect a deep understanding of human emotions and relationships, making them resonate with a wide audience. As she continues to write and create, readers eagerly anticipate the next masterpiece from this gifted author.

CONTACTS:

For more details on Kay A. Oliver’s works and accolades, visit her official website https://kayaoliver.com

Movie rights are currently being shopped. Contact dmarshal@liveamazinglynow.com for further information

For media inquiries or interview requests, please contact: dmarshal@liveamazinglynow.com

Media Contact
Company Name: Literary Titan
Contact Person: DMarshal
Email: Send Email
Country: United States
Website: https://kayaoliver.com/

The Price of Passion – A Heart-Wrenching Tale of Love, Jealousy, and Tragedy by Artemios John Korkidis, Now Available on Kindle. Translated and Enhanced by Dr. Katherine E.A. Korkidis

Artemios John Korkidis presents The Price of Passion, a poignant and tragic novel exploring the complexities of a dysfunctional marriage. What should be a relationship built on trust and love becomes a web of jealousy, control, and despair.

Title: The Price of Passion: A Gripping Tale of Love, Jealousy, and Tragedy

Authors: Artemios John Korkidis and Dr. Katherine E.A. Korkidis

Format: Kindle and Paperback Editions

Release Date: April 1st 2023

Publisher: Dorrance Publishing Co.

Artemios John Korkidis, an acclaimed author from Crete, Greece, presents his compelling novel, The Price of Passion, now available in English on Kindle. This deeply moving story delves into the tragic complexities of a marriage fraught with jealousy and an insatiable need for control. Korkidis masterfully narrates the unraveling of a relationship that should have been built on trust and love, but instead spirals into madness.

The Price of Passion is a gripping tale that explores the depths of human emotions and the psychological intricacies that drive its characters. The novel is unique in its dual-perspective narrative, offering insights into the minds of both spouses as they navigate their tumultuous marriage. Through vivid storytelling and rich character development, Korkidis provides readers with a profound understanding of human weaknesses and the devastating consequences of unaddressed emotional turmoil.

Originally written in Greek, this powerful story has been translated and enhanced by Dr. Katherine E.A. Korkidis, the author’s daughter. Dr. Korkidis, who holds a Ph.D. in Biophysical Chemistry, has dedicated herself to preserving her father’s literary legacy. Her translation not only retains the essence of the original work but also adds new depth to the narrative, making it accessible to a broader audience. The collaboration between father and daughter brings a unique dynamic to the novel, blending Artemios John Korkidis’ storytelling prowess with Dr. Korkidis’ meticulous attention to detail.

Artemios John Korkidis’ journey from the idyllic island of Crete to the bustling city of New York is as captivating as his novels. As a young man, he migrated to New York City, where he wrote for the National Herald and raised his family. Surrounded by his cherished family members, Korkidis lived his life doing what he loved: painting, writing, and inspiring others. The Price of Passion is his third book, a testament to his enduring passion for storytelling and his ability to touch the hearts of readers worldwide.

Dr. Katherine E.A. Korkidis’ contribution to this project is a labor of love and respect for her father. Her efforts have ensured that his life’s writings will be preserved for generations to come, allowing readers to experience the depth and richness of his stories.

The Price of Passion is now available for purchase on Amazon Kindle. For more information about the book, upcoming events, or to schedule an interview with Dr. Katherine E.A. Korkidis, please contact:

Contact Information:

For more information, please contact:

Dr. Katherine E.A. Korkidis

Award – Winning Author

katherinekorkidisauthor@gmail.com

Website: https://katherinekorkidisauthor.com/

Social Media: FB – https://www.facebook.com/KatKorkidis

X – https://x.com/KatKorkidis

Instagram – https://www.instagram.com/katkorkidis/

Pinterest – https://www.pinterest.com/KeakAuthor/

Media Contact
Company Name: Literary Titan
Contact Person: Dr. Katherine E.A. Korkidis
Email: Send Email
Country: United States
Website: https://katherinekorkidisauthor.com/

Dennis Wong Releases The App I Cot 6 Series: A Coloring Book Edition – Empowering Children to Overcome Adversity Through Engaging Stories

Dennis Wong releases “The App I Cot 6 Series: A Coloring Book Edition,” empowering children to overcome adversity.

Dennis Wong proudly announces the release of his innovative and inspirational six-book series, “The App I Cot 6 Series: A Coloring Book Edition.” This engaging and educational series combines the joys of storytelling with the creativity of coloring, making it an ideal tool for children to learn valuable life lessons in an interactive and fun way.

“The App I Cot 6 Series: A Coloring Book Edition” follows the adventures of Appy, an app character who embarks on various journeys to better himself, face challenges, and ultimately achieve personal growth and success. Each book in the series addresses different stages of Appy’s life, offering children relatable stories about overcoming adversity, the importance of education, resilience, and the value of family and community.

The App I Cot Journey to Plumville – Empowering Kids to Overcome Adversity: Appy travels to Plumville, where he encounters bullying but learns to overcome it, teaching children the importance of perseverance and self-belief.
The App I Cot Goes to College: Appy’s journey continues as he goes to college, graduates as an engineer, and embarks on a career that takes him around the world, highlighting the significance of education and determination.
Appy Overcomes Covid: In this timely installment, Appy and his family navigate the challenges of the COVID-19 pandemic, addressing themes of fear, anxiety, and resilience.
Appy Retires: Appy reflects on his fruitful career and enjoys his retirement, demonstrating the rewards of hard work and dedication.
Grand Appy’s Family: Appy looks forward to being a grandfather, emphasizing the joy and fulfillment of family life.
Grand Appy’s Achievement: Appy and June receive a Lifetime Award in Engineering, celebrating their accomplishments and legacy.

Key Features:

Interactive Coloring Book: Each book in the series includes coloring pages that allow children to engage with the story creatively.
Life Lessons: The series addresses important themes such as bullying, education, resilience, family, and overcoming challenges.
Relatable Characters: Appy’s journey is designed to resonate with children, helping them see themselves in his experiences and learn from his growth.

About the Author:

Dennis Wong is a dedicated author with a passion for creating stories that inspire and educate children. Through “The App I Cot 6 Series,” Wong aims to empower young readers to overcome adversity, embrace education, and value their family and community.

“The App I Cot 6 Series: A Coloring Book Edition” is available now on Amazon. For more information, review copies, or to schedule an interview with Dennis Wong, please email them at info@theappicot.com.

About Ink Start Media

Ink Start Media is dedicated to publishing works that inspire, inform, and impact readers. Our mission is to bring stories of hope, resilience, and faith to the forefront, empowering individuals to overcome their challenges through the power of literature.

Media Contact
Company Name: Ink Start Media
Contact Person: Sage Grey
Email: Send Email
Country: United States
Website: https://www.amazon.com/s?k=Forsaking+ONE+FLING+TOO+MANY…%3A+FOR+LOVE+In+MANY+WAYS&i=stripbooks-intl-ship&crid=199V0EPW521MJ&sprefix=forsaking+one+fling+too+many…+for+love+in+many+ways%2Cstripbooks-intl-ship%2C748&ref=nb_sb_noss:

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Dennis Wong Releases The App I Cot 6 Series: A Coloring Book Edition – Empowering Children to Overcome Adversity Through Engaging Stories

Prime Pressure Washing Delivers Top-Quality Power Washing Services to the Greater Augusta, GA Area

“A wooden deck, pictured before and after the pressure washing process.”

Prime Pressure Washing is proud to provide a comprehensive range of power washing services, available to residents and businesses throughout the greater Augusta, GA area. As a locally-owned and operated company, Prime Pressure Washing is dedicated to providing top-tier cleaning services at fair and competitive prices.

With an uncompromising commitment to quality and customer satisfaction, Prime Pressure Washing offers an extensive array of power washing solutions – including both pressure washing and soft washing – designed to meet the diverse needs of homeowners and commercial clients alike. Their expert team uses advanced techniques and equipment to ensure each job is completed efficiently and effectively, leaving properties looking pristine and well-maintained.

Prime Pressure Washing’s service portfolio includes:

House and Roof Soft Washing: Gentle yet effective cleaning methods to remove dirt, mold, and mildew without damaging delicate surfaces.

Concrete Cleaning: High-pressure cleaning for driveways, sidewalks, and other concrete surfaces, restoring their original appearance and improving curb appeal.

Deck and Fence Cleaning: Specialized cleaning to remove grime and buildup from wood and composite materials, prolonging the life of wooden elements.

Shed and Outbuilding Washing: Prime uses the appropriate combination of cleaning methods to tackle the exterior of sheds and other buildings, ensuring they contribute positively to the overall curb appeal of a property.

“Our mission at Prime Pressure Washing is to deliver exceptional results with a focus on customer satisfaction,” said Frank Jimenez, owner of Prime Pressure Washing. “As a local business, we take pride in serving our community and ensuring that every job is done right. We believe in providing high-quality services at fair prices, so our customers can enjoy clean and beautiful properties without breaking the bank.”

Prime Pressure Washing’s commitment to excellence is evident in their meticulous attention to detail and dedication to client satisfaction.

Key Highlights of Prime Pressure Washing:

Locally-Owned and Operated: Deep-rooted commitment to the Augusta community.

Quality Service at Fair Prices: Competitive pricing without compromising on service quality.

Comprehensive Range of Services: From soft washing to high-pressure cleaning, tailored to meet various property needs.

Property-Friendly Practices: Technicians will rinse plants and vegetation adjacent to home or other surface with water before, during and after applying cleaning solutions to avoid damage.

For more information about Prime Pressure Washing and their services, visit their website or contact them at (706) 550-1793.

About Prime Pressure Washing:

Prime Pressure Washing is a leading provider of power washing services in the greater Augusta, GA area. Specializing in house washing, roof washing, concrete cleaning, and deck and fence cleaning, the company is committed to delivering outstanding results and exceptional customer service. As a local business, Prime Pressure Washing takes pride in serving their community with integrity and professionalism.

Media Contact
Company Name: Prime Pressure Washing LLC.
Contact Person: Frank Jimenez
Email: Send Email
Phone: 706-830-5715
City: Augusta
State: GA
Country: United States
Website: https://www.primeaugusta.com/

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Prime Pressure Washing Delivers Top-Quality Power Washing Services to the Greater Augusta, GA Area

David Dodd O’Neal Junior Discusses the Intersection of Technology and Wellness

David Dodd O’Neal Junior, Los Angeles, California

Los Angeles Entrepreneur David Dodd O’Neal Junior Discusses the Intersection of Technology and Wellness

In a recent interview, David Dodd O’Neal Junior, a Los Angeles-based entrepreneur and business management consultant, shared deep insights into his journey through the evolving landscape of health tech and wellness. With a career beginning in digital marketing and transitioning through a significant tenure at the software startup Procore, David has been at the forefront of integrating cutting-edge technology with traditional wellness practices.

Throughout the interview, David spoke candidly about the motivations that drive him, particularly during challenging times. “When challenges arise, my motivation stems from a combination of personal ambition and the desire to make a positive impact on others’ lives through my work in health and wellness,” David stated. He emphasized that every obstacle is seen as an opportunity to learn and grow, keeping him focused on his goal to revolutionize how people interact with health technologies.

David also outlined both the surprisingly easy and difficult aspects of his job. He finds networking and staying informed within the health tech field relatively straightforward, thanks to his background and passion for the subject. However, he acknowledged the complexities of navigating regulatory environments and securing funding as ongoing challenges.

Highlighting the best aspects of his work, David expressed his love for innovation, the impact on people’s health, and the dynamic nature of the tech industry, which continuously drives him to learn and adapt. “Developing new solutions that integrate seamlessly into daily life and improve health outcomes is incredibly rewarding,” he remarked.

On achieving a sense of purpose in his work, David noted the importance of clarity, impact, and innovation. These elements ensure that his team is aligned, motivated, and constantly pushing the boundaries of what is possible in the health tech space.

The entrepreneur also shared a personal anecdote about an unexpected challenge during the early stages of his startup. A prototype intended to reduce user stress through guided meditations had the opposite effect, leading to confusion and increased stress among users. This experience underscored the importance of user-centered design and testing, a lesson that has profoundly shaped his approach to product development.

As for personal values, David places the highest importance on integrity, innovation, and impact. These guide his decisions and actions, ensuring that his business not only succeeds financially but also improves well-being.

David celebrates his victories by acknowledging his team’s hard work and taking personal time to reflect and recharge, often in nature. His favorite book, “Good to Great” by Jim Collins, has been instrumental in shaping his leadership and business strategies.

In closing, David shared advice for his younger self, emphasizing the importance of building meaningful relationships, embracing patience, and being open to change.

For more insights from David Dodd O’Neal Junior or to learn more about his entrepreneurial journey in health tech, please read the full interview here.

Media Contact
Company Name: David Dodd O’Neal Junior
Email: Send Email
City: Los Angeles
State: California
Country: United States
Website: https://www.daviddoddoneal.com/

M3 DAO Invests $1 Million in U-topia Fueling MediaFi Growth

Dubai, United Arab Emirates – July 9, 2024 – U-topia, a groundbreaking Web3 company propelling a new vision of MediaFi, has received a strategic investment worth 1 million USD from M3 DAO, a leading decentralized autonomous organization.

This investment is a landmark achievement for U-topia, which will help fuel its development of the innovative MediaFi platform and accelerate its mission to give creators and fans a voice in the entertainment industry.

This investment from M3 DAO will directly contribute to accelerating U-topia’s product development roadmap. This includes the further development of U-topia’s core MediaFi technology, which utilizes blockchain technology and a 70k Real World Assets catalog to change the paradigm of fan experiences and ownership within the media industry.

“We are thrilled to partner with M3 DAO, a visionary organization that shares our passion for Web3 innovation,” said Emmanuel Quezada, CEO of U-topia. “This investment is a step towards our vision for the future of MediaFi and empowers us to create a more equitable and rewarding experience for both fans and creators.”

In addition to the investment by M3 DAO, U-topia has the pleasure of announcing the appointment of Gerald Check as its Chief Investment Officer (CIO), who has been actively involved in the blockchain and venture capital industries. Mr. Check, also a core contributor at M3 DAO, has extensive experience recognizing and accelerating promising blockchain startups, having previously served as a professional at reputed organizations like Binance, TG20, and MEXC Global.

“I am incredibly impressed by U-topia’s work towards the future of fan engagement and ownership,” said Mr. Check. “The MediaFi concept has the potential to fundamentally transform the way we interact with the media we love. I am excited to join the U-topia team and leverage my experience to contribute to the company’s continued growth and success.”

By utilizing Web3 technology, U-topia will empower fans and general audiences alike and help them become actively engaged in the stories they cherish, while also creating new ways for creators to interact with their audiences and monetize their work in a better way.

About U-topia

U-topia is the leading MediaFi Company in the World, it is the convergence of innovative global IP Licensing in GameFi, AI Music, and Video Entertainment backed by a catalog of 70k Real World Assets rewards, leveraging top Intellectual Property (IP) from Web2 such as content from sports matches by professional teams, video content like Bandai Namco, and Top 100 retailers like Nike along with prime NFT collections from Web3.

About M3 DAO

M3 DAO is a decentralized autonomous organization focused on identifying and supporting high-potential blockchain startups. M3 DAO leverages the collective intelligence of its global community to make investment decisions, fostering a more democratic and inclusive approach to venture funding.

Media Contact
Company Name: U-Topia
Contact Person: Minrie Macapugay
Email: Send Email
City: Dubai
Country: United Arab Emirates
Website: https://u-topia.com/

Songwriter’s Pad Announces All New App With AI Lyrics Generator Powered By OpenAI

Songwriter’s Pad has helped songwriters break through writer’s block for more than a decade. Its all new app features an AI Lyrics and Ideas Generator that delivers lyrical suggestions in moments that music makers can use to fuel their writing sessions.

The Songwriter’s Pad Lyric Generator team is thrilled to announce the integration of AI technology based on OpenAI’s ChatGPT 4. Songwriter’s Pad has helped more than 350,000 songwriters break through creative blocks and write better songs since 2010. Now, all users can take advantage of the new AI features; Legacy users can gain free access by simply updating their apps.

Writer’s block is a notorious pain point for songwriters, which leads to reduced productivity, heightened frustration, and even burnout. There are a number of strategies that songwriters can implement to help them overcome writer’s block, including using writing prompts, using random word generators, and even changing their environment. Even with a strategy in place for overcoming creative blocks, songwriters often sacrifice precious time in doing so.

That’s where Songwriter’s Pad comes in. This easy to use platform offers mobile, desktop, and online versions of its app so that songwriters can access it around the clock from any device, whether they’re at home, in the studio, or on the go.

Songwriter’s Pad is the tool of choice for Gold record, Grammy-nominated songwriter, Dave Rudolph who has created 42 albums. He says, “I love Songwriter’s Pad and have been using it since its inception. I have recommended the app many times in both workshops and to fellow musicians.”

Now, Songwriter’s Pad has announced an AI generative feature that will help songwriters create new lyrical concepts in as little as 10 seconds that they can edit and make their own. Users can eliminate writer’s block forever by simply entering a few prompts and watching Songwriter’s Pad lyric generator work its magic. This is a platform that is used by Grammy winning artists and indie artists alike – it truly empowers users to create lyrical masterpieces.

The AI lyric generator is now a core feature of Songwriter’s Pad and is revolutionizing how people use this trusted platform. Results are delivered instantly, and artists can save and sync their lyrics across devices. The platform is affordable and risk-free for all users. Artists can get started for free with Songwriter’s Pad. A full walkthrough of Songwriter’s Pad and this groundbreaking AI lyric assistant can be found on YouTube. The Songwriter’s Pad AI upgrade is available for free for all Legacy users. Learn more now by visiting https://songwriterspad.com.

ABOUT SONGWRITER’S PAD

Songwriter’s Pad is a pro lyric writing app offering easy-to-use tools like an AI Lyric Generator, Idea Generator, Rhyme Lookup, and Audio Recorder to streamline the songwriting process and help artists break through creative blocks. It works seamlessly across Web, iOS, Android, Mac, and Windows devices so songwriters can keep their best ideas with them and create whenever and wherever inspiration strikes. It’s the ultimate all-in-one tool for anyone looking to write better songs, faster.

Media Contact
Company Name: Dante Media LLC
Contact Person: Dante Moore
Email: Send Email
Phone: 609-380-3185
City: BURLINGTON
State: NEW JERSEY
Country: United States
Website: https://songwriterspad.com/